Purchase Order 75N92B24P00107

Award Date 8/13/24
Potential Completion Date 8/12/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Haven, CT 06519, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $22,000 firm fixed-price purchase order contract was awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH), to Atlasxomics Inc., a biotechnology company specializing in spatial multi-omics technologies. The contract is for the delivery of hardware starter kits, sample optimization kits, and spatial ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) kits to support NIAMS'...
This is a $52,500.00 firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Atlasxomics Inc., a biotechnology company specializing in spatial multi-omics technologies. The contract is for ATAC sequencing analysis of 15 samples, which supports NCI's research into chromatin accessibility and gene regulation in cancer. The original contract opportunity was a sole-source procurement for Atlasxomics' proprietary...
Atlasxomics Inc. has been awarded a $21,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases to provide laboratory and testing services in support of the agency's research programs. The contract has a period of performance of just over one year, running from December 2023 through December 2024. Work will be conducted by Atlasxomics at its New Haven, Connecticut facility. No major subcontractors or set...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to 10X Genomics, Inc., a small business manufacturer of life sciences technology products. The $204,478.68 firm fixed price purchase order is for the supply of 10X Genomics' Multiome and single-cell ATAC kits, including dual index kits, single index kits, gene expression reagent bundles, and related microfluidic chips. This...
This firm fixed-price purchase order contract was awarded by the National Center for Advancing Translational Sciences, a component of the National Institutes of Health within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $22,349.00 award is for the delivery of 10X Genomics' specialized kits, instruments, and associated services to support biomedical research activities. The contract does not have a set-aside designation. As a prime contractor, 10X Genomics has...
This is a $95,474.20 firm fixed price delivery order contract awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. to provide single cell RNA sequencing and ATAC sequencing kits. The contract has an ultimate completion date of August 24, 2024. As the prime contractor, 10X Genomics, a life sciences technology company, will supply specialized genomic analysis products and related services to support biomedical research efforts....
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' Office of Logistics and Acquisition Operations to 10X Genomics, Inc., doing business as 10X Genomics. The $49,121.00 contract provides specialized genomics analysis products and services to support biomedical research efforts, primarily for the NIH and its various institutes and centers. The products include kits for single-cell RNA sequencing, single-cell ATAC sequencing, single-cell...
This is a firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $17,332.00 contract is for the delivery of 10X Genomics' products and services for single-cell and spatial analysis applications, including specialized kits, instruments, and associated installation, training, and support services. The contract has a period of...
This is a firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to 10X Genomics, Inc. as the prime contractor. The $52,750.00 contract is for the delivery of 10X Genomics' products and services related to single-cell and spatial analysis applications, including specialized kits, instruments, and associated installation, training, maintenance, and support. The end date for the contract is August 8, 2025. This award is not associated with...
The Department of Health and Human Services' National Institutes of Health (NIH) has awarded a firm fixed price contract to 10X Genomics, Inc. for the provision of specialized genomic analysis kits and instruments. The contract, valued at $14,881.00, provides 10X Genomics' Dual Index Kit TS Set A, Visium CytAssist for FFPE Spatial Gene Expression 11mm Kit, and associated shipping and handling. This contract supports the NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases'...

This is a $14,000 firm fixed-price purchase order contract awarded to Atlasxomics Inc. by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian agency. The contract is for the delivery of hardware starter kits, sample optimization kits, and spatial ATAC-seq kits to support the agency's genomics and cancer research. Atlasxomics is a biotechnology company that specializes in spatial multi-omics technologies, including its proprietary Deterministic Barcoding in Tissue for Spatial Omics Sequencing (DBiT-seq) platform. The contract has no set-aside designation, and no major subcontractors were indicated. Atlasxomics has also received multiple federal grants from the National Human Genome Research Institute and the National Cancer Institute to advance its spatial biology and epigenomics capabilities, reflecting the company's ongoing efforts to innovate in these research areas.

Generated 8/15/24, 9:16 AM